Cerevel Therapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $19.7M, a 8.24% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $19.7M -$1.77M -8.24% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $20.1M -$1.7M -7.77% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $20.6M -$1.62M -7.31% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $21M -$1.56M -6.9% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $21.4M -$1.49M -6.51% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $21.8M -$1.43M -6.16% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $22.2M -$1.37M -5.82% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $22.6M -$1.32M -5.51% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $22.9M -$1.26M -5.21% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $23.3M -$1.21M -4.94% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $23.6M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $23.9M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $24.2M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $24.5M -$1.56M -5.98% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $26M Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.